Becton, Dickinson: Our New, Long, Special Situation Investment

Hinde added Becton, Dickinson and Company (BDX) as a special situation investment. Uncover its spin-off and the value unlock.

Hinde Group Q3 2025 Partner Letter

Explore our Q3 2025 performance, including a 13.93% net return, driven by the AI boom and key tech holdings. Learn about our ...

Here’s Hinde Group’s Investment Thesis for Becton, Dickinson and Company (BDX)

Hinde Group, an investment management company, has released its third-quarter 2025 investor letter. A copy of the letter can ...

SC asks states to declare ESZs around tiger reserves bans mining activities within 1 km

In a significant verdict, the Supreme Court on Monday issued a slew of pan-India directions asking the state governments to notify Eco-Sensitive Zones around all tiger reserves, including buffer and ...
Le Lézard

Henlius and Organon Announce US FDA Approval of POHERDY® (pertuzumab-dpzb), the First PERJETA (pertuzumab) Biosimilar in the US

Shanghai Henlius Biotech, Inc. (2696.HK), and Organon today announced that the US Food and Drug Administration (FDA) has approved the Biologics License Application (BLA) for POHERDY® (pertuzumab-dpzb) ...
The Malaysian Reserve

New long-term data reinforces TREMFYA® (guselkumab) as the only IL-23 inhibitor proven to substantially inhibit structural joint damage in active psoriatic arthritis

First-line treatment with TREMFYA® shows significant inhibition of radiographic progression at Week 24, which was sustained through Week 48, preserving ...